Since its establishment in 2013, BSAZ has consistently stood at the forefront of synthetic biology, dedicated to becoming an innovative leader in the field of bio-based products. Leveraging cutting-edge synthetic biology as our foundation, we have meticulously developed the IVBT (in vitro BioTransformation) technology platform. This platform serves as the engine, driving the commercialization of diverse innovative products across critical sectors such as pharmaceuticals, chemicals, new materials, food, agriculture, and energy.
BSAZ Bio's mission is to empower various industries to achieve green, high-quality development and jointly create a healthier, more sustainable future. Our core R&D team comprises scientists from top global institutions, including Zhejiang University, ETH Zurich (Swiss Federal Institute of Technology Zurich), and the Max Planck Institutes in Germany. They have successfully pioneered the revolutionary ivBT in vitro biomanufacturing technology. This technology ingeniously reconstructs biochemical pathways through a sophisticated multi-enzyme cascade system, effectively overcoming the limitations of traditional microbial chassis and achieving unprecedented efficiency in biotransformation and energy conversion.
Leveraging its robust technological capabilities and promising market prospects, BSAZ Bio has successfully completed its Series B financing round, securing investments from renowned institutions, including the investment platform of the Tsinghua Yangtze River Delta Research Institute. We are deeply committed to industry-academia-research collaboration, possessing exceptional capabilities in transforming cutting-edge technology into tangible products. We look forward to partnering with global collaborators to collectively shape the boundless possibilities of biotechnology and fulfill humanity's aspiration for a better life.
At BSAZ, our team is young, dynamic, and vibrant, comprising members from China, Germany, India, the United States, and Switzerland. Over 70% of our team members hold master's degrees or higher. We adhere to a people-centric philosophy, striving to enhance human life quality through our products and services, and creating greater value through innovation and growth.
At BSAZ, we are committed to building a complete supply chain system that integrates R&D, production, and quality control. Our R&D scope covers pharmaceuticals, chemicals, new materials, food, agriculture, and energy, with over a hundred independent intellectual property rights. We adhere to the ISO9001 quality management system, comply with CMA metrology certification, and implement an HSE (Health, Safety, and Environment) strategy. We strictly control every stage from R&D and production to storage and marketing, ensuring quality while striving to minimize our environmental impact. Through our professional services and products, BSAZ has established trade partnerships with renowned companies in Europe, the Middle East, and other regions.
BSAZ upholds the principles of enterprise development driven by technology, prosperity through efficiency, revitalization through responsibility, and strength through talent. Through continuous independent innovation, stable operation, and a global orientation, we aim to build a comprehensive market network, establish a strong brand image, foster a unique corporate culture, and significantly enhance our core competitiveness. Our ambition is to develop into a technologically advanced, large-scale, financially robust pharmaceutical enterprise with significant influence in the global market.